Preview: Heron Therapeutics's Earnings
Portfolio Pulse from Benzinga Insights
Heron Therapeutics (NASDAQ:HRTX) is scheduled to release its quarterly earnings report on March 12, 2024, with analysts expecting an EPS of $-0.16. The company's past earnings performance shows a mixed impact on its stock price, with the last quarter's beat resulting in a 59.26% increase in share price. Shares are currently trading at $2.6, reflecting a 12.17% increase over the last 52 weeks. Investors are advised to pay attention to the company's guidance for future growth.
March 11, 2024 | 3:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Heron Therapeutics is expected to report an EPS of $-0.16 for the upcoming quarter. Historical data shows significant stock price movements post-earnings announcements.
Given Heron Therapeutics' history of stock price increases following earnings beats, and considering the current analyst expectations, a positive earnings surprise could lead to a short-term stock price increase. The company's guidance will also play a crucial role in influencing investor sentiment and stock performance.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100